Pom Wonderful announces new ad campaign
LOS ANGELES — Pom Wonderful, a producer of refrigerated juices, is celebrating the joys of pomegranate season with a new ad campaign. The company will return to television with a "Crazy Healthy" commercial campaign this month. The four commercials will focus on the antioxidant power of premium pomegranate juice and will feature people in everyday situations being protected by a number of radical-fighting characters.
“Consumers love the sweet burst of flavor and versatility of our products,” said Dahlia Reinkopf, senior director of marketing, POM Wonderful. “'Our ‘Crazy Healthy’ TV campaign is timed perfectly with the launch of POM season to remind people about the antioxidant power of pomegranates. The goal of our campaign is to inspire consumers to get crazy healthy with our premium 100% Pomegranate Juice and seasonal Wonderful variety pomegranates.”
Pom Wonderful products are available in the produce section at grocery, club and mass retailers.
Keurig, W.B. Mason partner for new K-Cups
WATERBURY, Vt. & BROCKTON, Mass. — Keurig Green Mountain and W.B. Mason have reached an agreement to offer W.B. Mason's Shazam coffee in K-Cup packs for the Keurig's line of brewing systems. Shazam will be the first brand to join the Keurig family from a Keurig authorized distributor, according to the companies.
“We’ve had a long, successful history with W.B. Mason as a Keurig Authorized Distributor,” said John Whoriskey, president, U.S. sales and marketing for Keurig. “By expanding our relationship and introducing Shazam coffee to office and hospitality channels, we’ll be able to provide even more variety and choice of beverages to customers across the country.”
The companies plan to launch the new K-Cup packs late this month, with varieties to include light, medium and dark roast blends. The product will be exclusive to W.B. Mason customers.
Mylan launches generic Combivir
PITTSBURGH — Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength. The drug is the generic version of Combivir from Viiv and is indicated for the treatment of HIV-1 infection in combination with other antiretroviral medications.
Lamivudine and zidovudine tablets USP, 150 mg had sales in the United States of $118.5 million for the 12 months ending June 30, according to IMS Health data.
Loading Post Please Wait...